This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CORPUS_UTERI_EXALLC for full statistics.
Malignant neoplasm of corpus uteri
C3_CORPUS_UTERI
endometrial carcinoma: A malignant tumor arising from the epithelium that lines the cavity of the uterine body. The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases. Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma. Uterine bleeding is an initial clinical sign. The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2958 |
4. Check minimum number of eventsNone |
2958 |
5. Include endpointsNone |
2958 |
6. Filter based on genotype QC (FinnGen only) |
2958 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of corpus uteri
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2958 | 2958 | - |
| Unadjusted period prevalence (%) | 1.01 | 1.01 | - |
| Median age at first event (years) | 65.35 | 65.35 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2768
- Matched controls
- 27679
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
516.7
323.0
401
9
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
2614.5
323.0
1583
14
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
2674.6
323.0
2240
43
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
86.5
323.0
941
164
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
303.9
323.0
414
16
N95.0
ICD-10 Finland
Postmenopausal bleeding
10.3
323.0
1353
2353
128
Kela drug reimbursment
Cancers of female genital organs
46.9
323.0
767
224
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
32.8
323.0
1527
999
ZXC96
NOMESCO Finland
Robot assisted procedure
74.9
323.0
509
83
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
323.0
645
*
B01AB10
ATC
tinzaparin; parenteral
9.4
323.0
773
1090
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.6
323.0
588
501
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
453.8
323.0
705
21
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
7.6
313.9
838
1497
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.6
297.9
1520
5781
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
6.2
291.3
923
2057
WF003
NOMESCO Finland
Adjuvant radiotherapy
13.2
291.1
541
501
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
10.5
286.3
601
710
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
999.1
281.2
271
*
LCA06
NOMESCO Finland
Biopsy of endometrium
5.2
256.1
963
2568
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
55.6
224.1
267
53
B01AB05
ATC
enoxaparin; parenteral
3.7
222.5
1549
7113
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
374.9
211.0
210
6
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
7.9
207.1
514
776
LCD00
NOMESCO Finland
Hysterectomy
6.5
199.4
579
1089
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
266.3
195.5
198
8
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
5.3
191.6
669
1570
C54.19
ICD-10 Finland
Malignant tumor of endometrium, unspecified histology
402.2
190.3
189
5
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
152.2
188.1
198
14
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
390.7
185.0
184
5
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
44.5
181.1
225
55
JN4BD
NOMESCO Finland
Extensive body CT
4.7
176.9
699
1857
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
16.5
147.7
244
161
1820A
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]
1516.9
147.2
142
*
8441/3-C54.1
ICD-O-3
Serous carcinoma, NOS, of endometrium
+∞
143.0
136
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.1
135.5
400
743
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
130.2
124
*
LE090
NOMESCO Finland
Profylactive radiotherapy of vulva and vagina
663.3
129.6
127
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
21.1
123.5
186
94
JN4AD
NOMESCO Finland
Body CT examination
4.7
119.4
453
1112
XX3DW
NOMESCO Finland
Time consuming IT work
3.9
113.4
540
1636
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
112.2
107
*
ULC02
NOMESCO Finland
Hysteroscopy
4.6
111.4
423
1035
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
21.9
109.6
163
79
H02AB02
ATC
dexamethasone; systemic
3.5
106.9
574
1911
C54.13
ICD-10 Finland
Clear cell carcinoma of the endometrium
1025.0
101.8
99
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
3.5
101.5
545
1808
JAL31
NOMESCO Finland
Laparoscopic omentectomy
46.9
95.5
117
26
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
29.9
93.0
126
44
A04AA01
ATC
ondansetron; systemic, rectal
4.0
91.3
401
1115
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
91.0
1149
6397
LEB00
NOMESCO Finland
Biopsy of vagina
8.6
89.0
202
252
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
45.4
85.2
105
24
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
81.3
899
4617
C54
ICD-10 Finland
Malignant neoplasm of corpus uteri
+∞
77.4
74
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.1
73.5
313
838
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
7.6
71.7
175
244
LCD30
NOMESCO Finland
Radical hysterectomy
56.3
69.3
82
15
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
12.0
68.9
129
112
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
68.9
788
4051
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
66.4
449
1711
C54.23
ICD-10 Finland
Carcinosarcoma
334.8
65.8
66
*
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
225.2
64.4
66
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
3.6
63.1
306
913
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
65.2
60.6
70
11
C54.22
ICD-10 Finland
Endometrial stromal cell sarcoma
590.3
58.9
58
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
8.2
58.8
135
171
WF099
NOMESCO Finland
Other radiotherapy
18.3
58.7
92
52
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
13.2
57.6
103
81
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
34.5
56.9
74
22
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
7.7
56.0
134
181
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.2
55.2
221
555
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
37.2
54.0
69
19
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
13.2
53.9
96
75
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
538.1
53.7
53
*
C54.0
ICD-10 Finland
Malignant neoplasm: Isthmus uteri
116.4
53.0
57
5
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.2
52.8
211
528
JAL30
NOMESCO Finland
Omentectomy
6.9
52.3
135
204
8310/3-C54.1
ICD-O-3
Clear cell adenocarcinoma, NOS, of endometrium
+∞
51.2
49
*
L03AA13
ATC
pegfilgrastim; parenteral
3.8
51.0
229
637
WX402
NOMESCO Finland
General anaesthesia
2.3
50.2
544
2663
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
49.4
410
1747
X77
ICPC
Malignant neopl genital female other
20.2
48.5
73
37
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.2
47.8
193
487
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
68.7
47.2
54
8
18200
ICD-8 Finland
Other malignant neoplasm of uterus, Carcinoma corporis uteri
233.7
45.1
46
*
LC003
NOMESCO Finland
Adjuvant radiotherapy of uterus and uterine ligaments
+∞
42.8
41
*
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
4.0
42.8
180
472
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
7.1
41.8
105
153
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
7.1
41.5
104
151
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
40.8
213
668
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
26.7
39.9
55
21
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
39.7
38
*
LCA10
NOMESCO Finland
Curettage of body of uterus
4.0
39.2
165
433
8140/3-C54.1
ICD-O-3
Adenocarcinoma, NOS, of endometrium
202.8
38.9
40
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.9
38.7
250
908
8980/3-C54.1
ICD-O-3
Carcinosarcoma, NOS, of endometrium
+∞
38.6
37
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
197.7
37.9
39
*
L03AA14
ATC
lipegfilgrastim; parenteral
5.1
37.4
123
252
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
4.7
37.0
129
282
N02BE01
ATC
paracetamol; systemic, rectal
2.2
36.1
2514
22659
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
39.7
34.4
43
11
B02AA02
ATC
tranexamic acid; systemic
2.0
33.4
484
2643
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.8
32.8
144
392
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.9
31.6
90
156
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.3
31.4
119
283
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
30.3
29
*
WF002
NOMESCO Finland
Radical radiotherapy
3.9
29.4
127
341
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
57.3
29.1
34
6
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
9.9
29.1
59
61
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
4.5
28.0
101
229
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
6.0
28.0
78
132
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
27.8
229
957
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
27.6
340
1727
JN4CD
NOMESCO Finland
Very extensive body CT
3.2
27.3
154
508
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
26.2
298
1463
C54.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of corpus uteri
+∞
26.1
25
*
Z51.5
ICD-10 Finland
Palliative care
2.4
25.4
223
963
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
0.1
25.4
12
964
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
14.1
25.3
43
31
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
11.7
24.4
45
39
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
6.5
24.3
64
101
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.6
24.2
86
193
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.8
24.1
160
592
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
22.9
23.9
34
15
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
23.9
727
4978
ULA02
NOMESCO Finland
Kolposcopy
2.1
23.1
280
1408
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
13.1
22.9
40
31
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.4
22.6
83
193
WZC30
NOMESCO Finland
Teaching
1.9
22.5
376
2139
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
16.1
21.9
35
22
8310
FHL
Radical hysterectomy (includes lymph node removal)
63.0
21.9
25
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
21.6
100
286
21899
ICD-8 Finland
Uterine fibroma
0.3
21.2
56
1647
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
0.3
21.0
65
1780
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
5.4
21.0
63
118
8931/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, low grade of endometrium
+∞
20.9
20
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.6
20.6
160
647
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
13.6
20.5
35
26
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
20.5
325
1813
WW500
NOMESCO Finland
Blood transfusion
2.7
20.0
142
545
ZXC40
NOMESCO Finland
Use of ultrasound
6.8
19.5
49
73
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.9
19.2
120
426
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
18.3
19.1
29
16
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
7.2
19.0
46
65
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
20.2
19.0
28
14
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.7
18.9
454
2888
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.1
18.9
75
189
JAL00
NOMESCO Finland
Biopsy of peritoneum
6.7
18.6
47
71
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.6
18.5
138
547
Z31.5
ICD-10 Finland
Genetic counselling
2.6
18.5
135
529
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.3
17.6
47
1379
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.8
17.4
74
199
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.4
17.2
84
253
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
17.2
1217
9856
JAH01
NOMESCO Finland
Laparoscopy
2.5
17.0
134
546
KA1FN
NOMESCO Finland
Isotope renography
8.7
16.9
36
42
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
9.5
16.9
34
36
A04AA55
ATC
palonosetron, combinations; systemic
2.8
16.8
111
409
A04AA03
ATC
tropisetron; systemic
8.5
16.7
36
43
G03AC03
ATC
levonorgestrel; systemic
0.5
16.6
103
2157
B01AB04
ATC
dalteparin; parenteral
2.2
16.6
180
863
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
16.5
215
1114
ZX120
NOMESCO Finland
Intravenous
1.8
16.2
281
1613
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
60.4
15.8
18
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
60.4
15.8
18
*
8980/3-C54.9
ICD-O-3
Carcinosarcoma, NOS, of corpus uteri
+∞
15.6
15
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.8
15.6
104
386
X12
ICPC
Postmenopausal bleeding
4.7
15.5
52
112
JEA00
NOMESCO Finland
Appendectomy
2.2
15.5
158
737
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.8
15.4
101
373
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
15.0
620
4486
Z51.0
ICD-10 Finland
Radiotherapy session
4.2
14.8
56
136
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
14.8
172
851
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
27.3
14.3
19
7
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.5
14.0
109
444
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.2
14.0
17
745
N02AA05
ATC
oxycodone; systemic
1.6
13.8
435
2953
R2110
NOMESCO Finland
Giving the first information
1.9
13.5
198
1071
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.2
13.5
41
80
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
13.4
126
566
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
18.3
13.4
20
11
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
11.5
13.3
24
21
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
16.8
13.0
20
12
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
4.1
12.7
49
122
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
10.5
12.7
24
23
L03AA02
ATC
filgrastim; parenteral
2.6
12.6
90
348
Z70.8
ICD-10 Finland
Other sex counselling
17.4
12.5
19
11
E66.9
ICD-10 Finland
Obesity, unspecified
2.5
12.2
95
389
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
12.1
184
1009
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
11.8
57
172
8305
FHL
Supravaginal amputation or resection
0.1
11.8
7
480
N81.1
ICD-10 Finland
Cystocele
0.5
11.8
116
2115
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
5.6
11.8
33
59
X75
ICPC
Malignant neoplasm cervix
65.2
11.6
13
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.4
11.6
41
95
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
11.5
174
953
8140/3-C54.9
ICD-O-3
Adenocarcinoma, NOS, of corpus uteri
+∞
11.5
11
*
8461/3-C54.1
ICD-O-3
High grade serous carcinoma of endometrium
+∞
11.5
11
*
8930/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, NOS, of endometrium
+∞
11.5
11
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
6.7
11.4
28
42
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.3
11.3
41
97
LCD11
NOMESCO Finland
Laparoscopically assisted vaginal hysterectomy
2.9
11.3
66
228
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
11.2
82
325
WF004
NOMESCO Finland
Palliative radiotherapy
3.2
11.2
58
186
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
11.1
77
1562
L02BG04
ATC
letrozole; oral
1.7
11.1
261
1642
R07.4
ICD-10 Finland
Chest pain, unspecified
0.7
11.0
468
6194
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
10.8
318
2114
A10BA02
ATC
metformin; oral
1.4
10.8
688
5359
E66.8
ICD-10 Finland
Other obesity
2.1
10.7
115
550
JAH00
NOMESCO Finland
Laparotomy
2.5
10.7
82
334
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.3
10.6
94
414
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.2
10.5
19
17
LCD97
NOMESCO Finland
Other laparoscopic hysterectomy
11.2
10.5
19
17
A79
ICPC
Malignancy NOS
3.5
10.5
48
140
T90
ICPC
Diabetes non-insulin dependent
1.4
10.5
577
4378
18220
ICD-8 Finland
NA
+∞
10.4
10
*
8323/3-C54.1
ICD-O-3
Mixed cell adenocarcinoma of endometrium
+∞
10.4
10
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.9
10.3
60
207
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.7
10.3
218
1333
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
18.8
10.3
15
8
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
7.9
10.1
22
28
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
11.3
10.0
18
16
C54.20
ICD-10 Finland
Malignant tumor of the myometrium without histology
40.2
10.0
12
*
N30.4
ICD-10 Finland
Irradiation cystitis
26.1
9.8
13
5
N93
ICD-10 Finland
Other abnormal uterine and vaginal bleeding
9.1
9.5
19
21
5703
FHL
Removal of lymph nodes from the retroperitoneal space
15.1
9.5
15
10
A46
ICD-10 Finland
Erysipelas
1.5
9.5
344
2403
R50.9
ICD-10 Finland
Fever, unspecified
1.5
9.5
297
2007
A04AA02
ATC
granisetron; systemic, transdermal
1.7
9.4
179
1060
8010/3-C54.1
ICD-O-3
Carcinoma, NOS, of endometrium
+∞
9.4
9
*
N93.8
ICD-10 Finland
Other specified abnormal uterine and vaginal bleeding
3.1
9.4
50
165
KA3EB
NOMESCO Finland
Antegrade pyelography
8.0
9.3
20
25
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
6.9
9.3
22
32
X81
ICPC
Genital neopl female other/unspecif
13.7
9.2
15
11
N81.6
ICD-10 Finland
Rectocele
0.6
9.1
117
1984
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
6.7
9.1
22
33
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
9.1
640
5045
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
1.9
9.1
129
693
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.1
9.0
98
473
K62.7
ICD-10 Finland
Radiation proctitis
24.1
8.9
12
5
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.1
8.9
46
149
LWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gynaecological surgery
12.6
8.9
15
12
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.1
8.8
47
155
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.3
8.8
43
133
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
8.8
99
485
WX704
NOMESCO Finland
Intubation
1.7
8.7
166
984
8308
FHL
Hysterectomy and bilateral adnexal removal
2.0
8.6
109
563
R03DC03
ATC
montelukast; oral
0.7
8.6
206
3037
B29
ICPC
Lymph/immune mech sympt/complt other
6.9
8.5
20
29
N84.1
ICD-10 Finland
Polyp of cervix uteri
2.1
8.5
95
466
R03BB04
ATC
tiotropium bromide; inhalant
0.5
8.5
85
1538
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.0
8.5
99
494
XLD10
NOMESCO Finland
Gynaecological examination
6.4
8.5
21
33
1XA02
NOMESCO Finland
NA
12.8
8.4
14
11
8980/3-C54.2
ICD-O-3
Carcinosarcoma, NOS, of myometrium
+∞
8.3
8
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
8.2
194
1221
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
8.2
565
4432
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
8.1
368
2689
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.6
8.0
56
219
G02BA03
ATC
plastic IUD with progestogen
0.5
8.0
49
1032
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.7
8.0
272
3763
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
0.6
8.0
119
1943
R03BA01
ATC
beclometasone; inhalant
0.7
8.0
192
2829
E66.00
ICD-10 Finland
Metabolic syndrome
1.9
7.9
117
638
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.0
7.9
101
523
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.5
7.8
56
1120
6170A
ICD-9 Finland
Endometriosis of uterus
0.1
7.8
*
277
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.0
7.7
29
73
N99.3
ICD-10 Finland
Prolapse of vaginal vault after hysterectomy
0.3
7.7
15
505
R01AD09
ATC
mometasone; nasal
0.8
7.7
780
9237
SPAT1262
SPAT
Handing over of treatment supplies
1.4
7.4
434
3309
LCA98
NOMESCO Finland
Other transluminal endoscopic operation on uterus
3.2
7.4
37
118
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
80.3
7.4
8
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
4.3
7.3
25
58
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.5
7.3
61
1162
18221
ICD-8 Finland
NA
+∞
7.3
7
*
J45
ICD-10 Finland
Asthma
0.6
7.3
113
1829
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
7.3
121
689
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.2
305
2196
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
3.8
7.1
28
74
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
10.0
7.0
13
13
WX720
NOMESCO Finland
Own respiration
2.0
7.0
81
403
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
7.0
258
1807
X14
ICPC
Vaginal discharge
2.9
7.0
40
139
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.8
7.0
27
71
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
6.9
2239
21170
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
5.8
6.9
18
31
HA1AA
NOMESCO Finland
X-ray mammography
1.4
6.9
295
2130
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.5
6.8
256
1797
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
6.8
70
1257
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
9.3
6.8
13
14
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.4
6.8
30
707
KKA10
NOMESCO Finland
Biopsy of retroperitoneal tissue
40.1
6.8
8
*
WX234
NOMESCO Finland
Paracervical blockade
3.0
6.7
35
117
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.6
764
6406
JFB00
NOMESCO Finland
Partial resection of small intestine
2.4
6.6
54
232
H02AB06
ATC
prednisolone; systemic
0.8
6.6
921
10584
N71.1
ICD-10 Finland
Chronic inflammatory disease of uterus
5.9
6.6
17
29
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.8
6.6
39
140
62533
ICD-8 Finland
Other diseases of uterus, Adenomyosis uteri
0.1
6.5
*
243
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
3.3
6.5
30
92
M03BX02
ATC
tizanidine; oral
0.8
6.4
1199
13392
R06AX27
ATC
desloratadine; oral
0.8
6.4
376
4788
6271A
ICD-9 Finland
Menopausal and postmenopausal disorders, Postmenopausal bleeding
2.1
6.4
66
317
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
9.3
6.3
12
13
LDA10
NOMESCO Finland
Curettage of cervix uteri
1.9
6.3
88
475
8020/3-C54.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of endometrium
+∞
6.3
6
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
7.0
6.2
14
20
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.2
6.2
30
95
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
2.9
6.1
33
113
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
549
785
8.36
307.65
1.4
1.5
209.7
228.8
pmol/l
0.18
542
763
1315
1968
11.23
307.65
5.1
4.0
38.7
79.7
u/ml
5.63
1294
1883
1875
12062
2.51
123.18
4.9
3.9
—
—
—
0
0
172
235
7.71
119.73
1.1
1.2
—
—
—
0
0
906
4873
2.24
81.27
1.5
1.3
—
—
—
0
0
1764
12483
2.02
73.31
4.4
4.1
34.4
35.0
g/l
3.91
1669
11390
244
831
3.11
55.01
3.2
3.6
3.8
3.8
mmol/l
0.20
233
786
388
1701
2.47
53.77
5.7
6.0
25.0
24.9
mmol/l
0.22
374
1582
743
4377
1.93
48.01
3.7
2.7
0.8
0.8
mmol/l
2.35
687
3986
558
3031
2.04
45.25
4.3
5.7
1.3
1.4
mmol/l
0.11
435
2418
557
3037
2.03
44.64
4.3
5.7
5.3
5.1
kpa
3.35
535
2885
555
3035
2.02
44.06
4.3
5.7
13.2
12.3
kpa
3.73
534
2874
475
2493
2.08
42.05
4.4
6.2
118.7
117.7
g/l
0.63
464
2398
479
2581
2.02
39.25
1.7
2.0
0.2
0.2
g/l
3.66
457
2387
965
6489
1.72
38.85
2.4
2.2
—
—
—
0
0
1787
14343
1.62
34.30
6.7
5.7
10.4
10.8
umol/l
0.66
1698
13459
1688
13394
1.61
33.70
5.0
4.6
0.0
0.0
estimate
1.08
321
2331
1670
13277
1.59
32.57
6.3
6.0
0.0
0.0
estimate
0.80
318
2290
323
1632
2.10
31.14
4.3
6.7
94.7
93.9
%
2.91
323
1625
1889
15680
1.57
28.74
4.3
4.2
6.9
6.7
mmol/l
4.20
1802
14611
1821
15006
1.56
28.49
11.2
8.8
4.0
4.0
e9/l
0.06
1617
12928
2154
18518
1.60
27.35
6.3
5.6
1145.4
3889.6
e6/l
2.98
56
246
576
3759
1.66
24.13
8.1
7.6
—
—
—
0
0
514
3310
1.67
22.52
5.0
5.5
104.1
104.0
mmol/l
0.21
502
3237
952
7091
1.51
22.16
5.7
5.1
0.0
0.0
estimate
0.80
309
2309
452
2863
1.68
20.98
3.6
3.6
—
—
—
0
0
1752
15017
1.41
17.71
5.8
5.9
1.2
1.2
mmol/l
19.02
1430
12503
1303
10637
1.40
17.42
3.3
3.3
2.4
2.4
mmol/l
0.51
1128
8959
346
2174
1.67
16.34
1.6
1.6
—
—
—
0
0
190
999
1.96
16.23
2.2
1.8
5.0
1.6
ug/l
1.27
161
855
2299
20835
1.46
16.03
8.1
7.2
84.8
79.6
u/l
3.99
2167
19297
328
2089
1.64
14.64
5.8
5.3
9.8
9.9
mmol/l
0.06
307
1969
1586
13603
1.36
14.60
5.1
5.3
1.2
1.2
mmol/l
17.58
1430
12082
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
166
866
1.97
14.51
2.7
2.8
0.4
0.4
u/ml
0.41
92
512
1203
9902
1.36
14.37
5.7
5.0
—
—
—
0
0
949
7600
1.37
13.22
4.2
3.0
31.3
33.8
u/l
0.83
902
7108
1522
13169
1.32
12.24
5.1
4.5
0.0
0.0
estimate
0.00
327
2330
119
599
2.03
11.55
4.0
6.0
105.6
104.5
mmol/l
2.02
110
538
195
1156
1.74
11.37
3.8
4.4
1.7
1.5
%
1.92
183
1087
744
5875
1.36
10.96
5.9
5.2
1.0
1.0
kg/l
0.23
80
953
455
3359
1.42
9.98
4.4
4.2
1.0
1.0
mmol/l
0.18
405
3028
305
2089
1.51
9.85
3.5
2.6
58.4
60.2
ml/min/173m2
0.46
135
891
2638
25089
1.48
9.66
18.8
15.8
31.8
22.8
mg/l
23.62
2271
20131
452
3354
1.41
9.61
3.3
3.7
5.9
23.8
ug/l
2.96
362
2696
188
1161
1.66
9.46
3.8
4.4
0.9
0.9
%
0.12
176
1093
338
2430
1.44
8.53
3.6
2.4
65.7
66.2
g/l
0.62
307
2135
696
5690
1.29
7.62
2.7
2.6
8.3
7.4
e6/l
0.57
602
4917
36
135
2.69
6.99
3.3
1.5
1465.2
133.6
u/l
0.48
20
62
1057
9178
1.24
6.78
3.0
3.0
1753.9
1420.0
ng/l
0.96
921
7842
312
2314
1.39
6.59
3.9
5.1
1.3
1.3
mmol/l
0.13
303
2235
32
118
2.73
6.44
3.1
3.3
—
—
—
0
0
2732
26441
1.44
6.31
22.7
18.6
139.4
139.6
mmol/l
3.41
2685
25703
26
87
3.01
6.22
1.3
2.2
2.9
2.6
ug/l
0.19
17
46
1219
10827
1.21
6.08
4.0
4.0
34.5
89.8
ng/l
0.76
942
7945
113
696
1.65
5.85
1.4
1.4
—
—
—
0
0
2732
26485
1.41
5.81
22.7
18.8
4.0
4.0
mmol/l
0.12
2681
25705
98
586
1.70
5.69
1.4
2.3
4.0
3.6
g/l
1.53
93
564
986
8622
1.22
5.66
2.9
2.4
54.4
57.9
u/l
1.41
901
7785
279
2118
1.35
5.11
2.5
2.7
4.5
4.4
kpa
0.21
268
2053
218
1598
1.39
4.97
1.4
1.5
—
—
—
0
0
1595
14707
1.18
4.84
3.5
3.0
50.8
47.9
u/l
0.53
1445
13185
107
688
1.58
4.72
1.7
1.6
—
—
—
0
0
322
2526
1.31
4.71
2.8
3.1
5.8
5.8
kpa
0.43
310
2462
53
281
1.90
4.64
5.0
4.1
7.7
7.3
mmol/l
0.32
42
230
328
2595
1.30
4.51
3.2
3.5
1.2
1.2
mmol/l
0.47
278
2211
859
7545
1.20
4.50
3.2
3.1
0.6
0.5
e6/l
0.34
667
5606
379
3059
1.27
4.45
2.9
2.3
1.9
1.9
%
0.35
324
2651
704
6079
1.21
4.43
2.9
3.0
2.5
2.5
mmol/l
2.38
627
5298
363
2922
1.28
4.36
3.8
3.8
248.4
252.1
u/l
0.21
340
2715
86
540
1.61
4.22
1.8
2.3
88.6
63.5
ug/min
0.34
44
288
317
2522
1.29
4.18
2.4
2.4
4.3
5.4
ug/l
1.12
265
2072
314
2502
1.29
4.10
2.8
3.1
2.3
2.2
mmol/l
0.14
251
2103
437
3624
1.24
4.07
2.4
2.4
18.4
20.3
%
2.27
355
2986
363
4425
0.80
4.03
1.2
1.2
11.8
15.4
u/ml
0.47
141
1552
463
3871
1.23
3.99
2.3
2.3
2.3
2.4
g/l
1.69
418
3511
471
3974
1.22
3.72
1.9
1.9
29.2
29.5
s
0.43
457
3836
391
4676
0.81
3.63
1.3
1.3
57.2
39.0
iu/ml
0.80
127
1501
87
577
1.52
3.44
1.6
2.3
231.8
201.6
%
2.01
81
547
627
7139
0.85
3.42
1.6
1.6
1.5
1.3
mmol/l
3.55
486
5886
37
195
1.91
3.38
1.4
1.5
—
—
—
0
0
663
5821
1.18
3.38
1.5
1.7
2.0
1.3
mg/l
2.69
528
4498
91
616
1.49
3.28
1.5
2.0
92.7
93.1
%
0.06
85
572
22
465
0.47
3.26
1.0
1.2
—
—
—
0
0
1152
12498
0.87
3.26
2.3
2.4
—
—
—
0
0
491
4218
1.20
3.20
2.3
2.3
10.6
11.9
umol/l
3.91
445
3824
489
5642
0.84
3.09
3.8
4.0
120.8
195.2
ng/l
0.82
395
4676
87
594
1.48
3.03
3.7
3.9
28.4
24.7
mg/l
0.39
61
366
129
949
1.38
2.99
1.3
1.2
—
—
—
0
0
88
605
1.47
2.97
2.7
2.1
126.0
124.6
g/l
0.25
65
429
14
54
2.60
2.70
2.2
2.4
0.5
9.7
ug/l
—
6
27
24
119
2.03
2.66
1.2
1.3
9.2
8.9
umol/l
0.03
19
74
65
431
1.52
2.65
2.2
3.3
1.3
1.6
%
0.35
51
330
86
606
1.43
2.60
2.3
2.9
100.0
998.0
u/ml
1.28
75
540
80
558
1.45
2.55
3.0
2.4
15.9
15.7
%
0.12
44
274
6
178
0.34
2.53
1.2
1.2
—
135.3
—
0
32
720
6491
1.14
2.53
1.7
1.7
32384814.2
25875002.7
pmol/l
0.10
562
5117
926
8488
1.13
2.52
4.0
3.7
7.2
7.5
mg/mmol
0.08
552
4724
52
790
0.65
2.46
1.6
1.7
—
—
—
0
0
781
7114
1.13
2.32
2.3
2.3
3.4
3.1
mg/l
1.41
665
5965
2696
26465
1.21
2.31
13.0
11.3
23.3
22.7
u/l
1.29
2589
25247
892
8195
1.13
2.31
3.1
2.9
6.2
6.0
mmol/l
1.26
728
6690
102
760
1.35
2.26
1.2
1.2
—
—
—
0
0
212
1739
1.24
2.26
3.3
2.9
4.5
4.4
pmol/l
0.28
185
1493
46
294
1.57
2.25
1.3
1.4
—
—
—
0
0
177
1424
1.26
2.24
4.1
3.3
1.8
2.4
mmol/l
0.94
135
1090
81
585
1.40
2.18
4.1
2.8
25.9
25.7
mmol/l
0.11
74
504
520
4631
1.15
2.17
1.8
1.8
—
—
—
0
0
37
231
1.61
2.02
1.2
1.4
—
—
—
0
0
41
265
1.55
1.95
1.6
1.3
17636.4
152995.1
e6/l
1.77
28
169
163
1324
1.24
1.93
2.1
2.4
1.2
1.1
%
0.59
163
1316
6
16
3.76
1.93
1.0
1.0
—
—
—
0
0
160
1298
1.25
1.92
2.1
2.4
0.8
0.7
%
2.87
153
1243
231
2724
0.84
1.90
2.6
3.0
204.6
204.7
ng/l
0.00
209
2488
502
5572
0.88
1.86
1.2
1.3
1.4
1.6
u/ml
0.20
124
1388
266
3090
0.85
1.84
1.5
1.3
—
—
—
0
0
5
12
4.17
1.82
1.6
1.1
—
—
—
0
0
79
1049
0.75
1.82
1.2
1.2
1.3
1.2
u/ml
0.04
15
101
2751
27127
1.20
1.80
30.3
23.7
6.7
6.6
e9/l
0.79
2684
26158
2750
27117
1.20
1.80
30.3
23.7
259.7
257.2
e9/l
1.11
2686
26262
181
1501
1.22
1.79
4.2
3.3
5.3
5.2
kpa
0.28
167
1367
2750
27122
1.20
1.76
30.3
23.7
4.2
4.3
e12/l
16.43
2683
26155
434
3878
1.14
1.74
27.8
27.8
1.4
1.4
inr
0.05
49
507
2750
27128
1.20
1.72
30.5
23.8
126.6
130.0
g/l
32.20
2717
26619
1278
12118
1.10
1.71
5.4
5.9
24.9
27.5
%
11.30
1171
11036
40
266
1.51
1.71
1.3
1.4
40949.0
69305.7
e6/l
0.38
21
153
7
162
0.43
1.66
1.0
1.1
—
—
—
0
0
44
301
1.47
1.65
1.3
1.4
920.6
2127.9
e6/l
2.02
29
223
16
83
1.93
1.64
1.2
1.7
—
—
—
0
0
136
1661
0.81
1.63
2.4
2.4
24.0
28.4
au/ml
—
6
67
2104
21620
0.91
1.63
20.0
17.7
36.6
37.9
%
4.95
1219
13554
5
14
3.58
1.61
1.0
1.3
—
—
—
0
0
38
255
1.50
1.58
2.5
3.0
—
—
—
0
0
324
2860
1.15
1.57
2.7
2.3
9.9
7.7
umol/l
0.64
271
2389
17
92
1.85
1.56
1.2
1.1
—
—
—
0
0
105
837
1.26
1.52
1.2
1.2
—
—
—
0
0
50
687
0.72
1.49
1.3
1.3
29.4
5.6
u/ml
—
8
129
122
1487
0.81
1.46
1.2
1.3
26.6
51.9
au/ml
—
6
73
15
266
0.56
1.44
3.4
3.6
—
—
—
0
0
765
7133
1.10
1.44
1.5
1.6
22.2
21.8
nmol/l
0.21
656
5889
2051
19949
1.09
1.43
23.5
19.6
14.2
13.9
%
12.53
2009
19441
103
828
1.25
1.41
1.2
1.2
—
—
—
0
0
37
254
1.46
1.40
3.1
2.4
4.1
2.1
u/field
0.52
13
79
2378
24238
0.90
1.40
4.5
4.7
1.5
1.6
mmol/l
13.07
2082
21575
1210
12685
0.92
1.40
2.3
2.3
80.5
81.8
nmol/l
0.86
1060
11057
272
2395
1.15
1.39
2.3
2.1
402.1
381.6
nmol/l
0.84
247
2153
83
653
1.28
1.36
1.2
1.3
—
—
—
0
0
138
1646
0.83
1.35
1.4
1.6
1.4
1.4
%
0.05
116
1388
2404
24476
0.90
1.33
4.5
4.7
4.7
4.8
mmol/l
1.02
2110
21948
22
136
1.62
1.32
1.3
1.2
—
—
—
0
0
22
136
1.62
1.32
1.3
1.2
—
—
—
0
0
1104
10495
1.08
1.32
2.7
2.8
160.2
113.9
ug/l
6.94
997
9412
51
681
0.74
1.30
1.5
1.5
0.0
0.2
iu/ml
1.97
12
156
47
634
0.74
1.28
1.4
1.7
3.5
3.7
mg/l
0.07
37
476
37
260
1.43
1.27
1.1
1.1
268.3
306.0
u/ml
0.31
14
156
127
1060
1.21
1.25
1.9
1.8
—
—
—
0
0
324
3600
0.89
1.25
4.5
4.8
33.4
34.5
%
0.96
187
2206
39
539
0.72
1.25
1.3
1.2
67.2
47.8
u/ml
—
6
73
2412
23684
1.10
1.23
18.6
15.1
72.9
73.2
ml/min/173m2
0.32
2110
19437
1248
11953
1.08
1.20
5.2
5.7
59.7
57.6
%
5.97
1152
10932
30
206
1.46
1.17
1.2
1.2
—
—
—
0
0
1235
11837
1.07
1.16
5.1
5.7
2.6
2.8
%
3.12
1140
10815
21
134
1.57
1.14
2.1
2.2
2.1
1.9
u/field
0.07
16
89
10
183
0.54
1.11
1.0
1.1
—
—
—
0
0
10
183
0.54
1.11
1.0
1.1
—
—
—
0
0
10
183
0.54
1.11
1.0
1.1
—
—
—
0
0
10
183
0.54
1.11
1.0
1.1
—
—
—
0
0
37
268
1.39
1.10
1.2
1.2
124.5
118.6
u/ml
0.20
13
57
95
1147
0.82
1.10
1.7
1.7
—
—
—
0
0
10
182
0.55
1.10
1.0
1.1
—
—
—
0
0
115
966
1.20
1.09
2.0
3.1
39.8
43.5
mg/l
0.16
90
790
38
277
1.38
1.09
1.1
1.1
—
—
—
0
0
115
967
1.20
1.08
2.0
3.1
35.5
110.3
mg/l
0.71
91
797
9
163
0.55
1.08
1.1
1.0
—
—
—
0
0
134
1146
1.18
1.05
2.0
1.8
—
—
—
0
0
40
533
0.75
1.05
1.1
1.1
—
—
—
0
0
5
22
2.27
1.03
9.4
15.9
4.0
4.8
mmol/l
—
5
22
49
376
1.31
1.03
1.2
1.3
—
—
—
0
0
124
1056
1.18
1.03
2.9
3.0
100.0
1428.7
u/ml
1.25
96
879
23
155
1.49
1.01
1.4
1.5
15.5
14.4
%
0.12
11
52
43
325
1.33
1.00
1.3
1.3
—
—
—
0
0
5
108
0.46
1.00
1.0
1.1
—
—
—
0
0
49
378
1.30
1.00
1.2
1.3
—
—
—
0
0
28
197
1.43
1.00
1.3
1.3
—
—
—
0
0
28
197
1.43
1.00
1.3
1.3
—
—
—
0
0
28
197
1.43
1.00
1.3
1.3
—
—
—
0
0
48
370
1.30
0.98
1.2
1.3
—
—
—
0
0
11
61
1.81
0.98
1.2
1.3
25.1
25.7
%
0.07
11
53
5
23
2.18
0.98
1.0
1.3
41.8
65.9
nmol/l
—
5
23
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
48
371
1.30
0.97
1.3
1.3
—
—
—
0
0
17
259
0.65
0.96
4.4
4.5
38.6
88.6
u/ml
—
5
72
128
1101
1.17
0.96
1.5
1.3
—
—
—
0
0
48
373
1.29
0.94
1.2
1.3
—
—
—
0
0
42
545
0.77
0.94
1.4
1.4
—
—
—
0
0
49
382
1.29
0.94
1.2
1.3
—
—
—
0
0
45
348
1.30
0.92
1.2
1.2
276.0
201.3
miu/ml
0.36
14
136
51
402
1.27
0.90
1.5
2.5
32.4
32.8
umol/l
0.05
43
332
73
600
1.22
0.90
1.4
1.5
—
—
—
0
0
351
3235
1.10
0.88
1.7
1.8
—
—
—
0
0
34
254
1.34
0.88
2.4
3.0
65.5
57.2
%
1.18
22
154
98
834
1.18
0.85
2.4
2.7
—
—
—
0
0
61
744
0.82
0.83
1.5
1.7
—
—
—
0
0
28
205
1.37
0.83
1.3
1.3
—
—
—
0
0
17
113
1.51
0.82
1.1
1.1
1.1
1.0
ratio
—
5
32
670
6359
1.07
0.82
2.6
2.5
6266.8
5825.6
umol/l
0.07
540
5262
99
848
1.17
0.81
3.5
3.3
0.8
0.8
nmol/l
0.87
80
662
140
1232
1.14
0.81
3.1
3.3
24.5
24.5
mmol/l
0.03
118
1109
45
356
1.27
0.80
1.4
1.3
—
—
—
0
0
46
365
1.26
0.80
3.1
3.6
137.9
360.5
iu/ml
—
7
42
9
147
0.61
0.79
1.0
1.6
10.2
12.3
umol/l
—
9
138
108
935
1.16
0.78
1.2
1.3
—
—
—
0
0
108
935
1.16
0.78
2.0
3.0
1.5
1.7
ratio
—
6
73
108
1243
0.86
0.78
1.1
1.1
—
—
—
0
0
20
281
0.71
0.78
1.1
1.1
—
—
—
0
0
498
4698
1.07
0.73
2.9
2.7
1.6
2.2
e6/l
0.39
290
2582
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
36
281
1.28
0.72
1.2
1.1
—
—
—
0
0
16
230
0.69
0.72
1.5
1.4
—
510.4
—
0
25
10
60
1.67
0.72
1.2
1.4
—
—
—
0
0
28
211
1.33
0.72
1.3
1.3
—
—
—
0
0
13
84
1.55
0.71
1.2
1.0
94.5
92.2
%
—
8
59
2489
25160
0.93
0.71
5.2
5.4
2.8
2.8
mmol/l
0.18
2184
22483
60
499
1.21
0.70
1.3
1.2
—
—
—
0
0
7
119
0.59
0.67
1.0
1.1
—
—
—
0
0
7
120
0.58
0.67
1.3
1.1
—
—
—
0
0
19
260
0.73
0.66
1.1
1.1
4.1
3.4
u/ml
—
5
84
10
62
1.61
0.65
1.1
1.1
—
—
—
0
0
26
198
1.32
0.64
1.3
1.8
5.1
4.0
mg/l
0.41
26
190
5
29
1.73
0.64
3.8
3.7
0.4
0.8
u/field
—
5
29
62
524
1.19
0.63
1.4
1.4
—
—
—
0
0
136
1220
1.12
0.62
1.9
1.6
1.7
1.6
g/l
0.23
105
1035
12
79
1.52
0.62
2.3
2.2
—
—
—
0
0
12
79
1.52
0.62
2.3
2.2
—
—
—
0
0
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
6
102
0.59
0.62
1.3
1.5
—
—
—
0
0
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
35
280
1.25
0.61
1.1
1.1
139.3
122.6
%
1.38
27
241
450
4265
1.06
0.60
3.1
2.9
4.8
4.5
e6/l
0.15
245
2163
49
409
1.20
0.58
1.4
1.3
—
—
—
0
0
346
3255
1.07
0.58
1.7
1.8
—
—
—
0
0
38
460
0.82
0.54
1.4
1.4
—
—
—
0
0
81
711
1.14
0.54
1.4
1.7
5.3
4.9
iu/l
0.09
31
218
11
159
0.69
0.54
3.5
1.7
—
—
—
0
0
79
693
1.14
0.53
2.9
3.0
1.7
1.6
mmol/l
0.25
79
680
107
1192
0.89
0.53
1.5
2.2
7.8
7.7
g/l
0.23
76
863
17
226
0.75
0.52
1.0
1.1
—
4.5
—
0
6
20
152
1.32
0.52
1.3
1.1
78.2
67.6
u/l
0.52
12
112
20
152
1.32
0.52
1.3
1.1
21.9
21.1
u/l
0.03
12
109
107
1190
0.90
0.52
1.5
2.2
—
—
—
0
0
100
1116
0.89
0.51
1.6
2.2
3.3
3.2
g/l
0.60
75
847
107
1189
0.90
0.51
1.5
2.2
4.0
3.7
g/l
0.96
75
824
23
179
1.29
0.51
1.3
1.0
—
—
—
0
0
858
8849
0.96
0.50
2.3
2.1
153.9
159.3
u/l
0.17
798
8186
20
153
1.31
0.50
1.5
1.5
—
—
—
0
0
104
935
1.12
0.49
4.3
3.7
24.4
25.3
mmol/l
1.62
93
832
24
191
1.26
0.46
1.3
1.3
1.9
1.5
nmol/l
1.12
24
169
59
514
1.15
0.46
3.1
3.5
60.8
58.1
%
0.92
59
514
17
130
1.31
0.44
1.2
1.3
—
—
—
0
0
41
480
0.85
0.43
1.4
1.3
36.7
41.1
iu/l
0.46
36
411
41
349
1.18
0.43
1.1
1.3
300.7
283.2
pmol/l
0.10
36
269
9
131
0.69
0.43
1.0
1.1
—
—
—
0
0
64
565
1.14
0.42
1.3
1.4
—
—
—
0
0
29
239
1.22
0.42
1.1
1.2
8.4
7.9
mmol/l
0.25
24
163
92
1016
0.90
0.42
1.6
2.2
0.4
0.8
g/l
1.10
70
848
6
95
0.63
0.42
1.0
1.1
—
—
—
0
0
15
195
0.77
0.41
1.1
1.1
—
—
—
0
0
8
58
1.38
0.41
1.0
1.3
—
—
—
0
0
86
952
0.90
0.41
1.6
2.1
36.7
37.2
g/l
0.35
69
782
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
16
205
0.78
0.40
1.1
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
3.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
80
885
0.90
0.39
1.6
2.2
0.0
0.1
g/l
0.72
67
795
282
2962
0.95
0.37
1.7
1.9
125.6
144.0
ug/g
0.47
205
2233
36
308
1.17
0.37
1.6
1.5
—
—
—
0
0
10
72
1.39
0.37
1.0
1.0
—
—
—
0
0
9
70
1.29
0.36
1.0
1.6
4.2
2.4
umol/l
—
9
62
9
70
1.29
0.36
1.4
1.2
—
—
—
0
0
125
1347
0.92
0.36
1.3
1.2
142.2
158.1
u/ml
0.20
118
1228
2314
23325
0.96
0.36
4.0
4.2
1.4
1.3
mmol/l
9.01
2007
20479
12
157
0.76
0.35
2.4
2.4
—
—
—
0
0
13
168
0.77
0.35
1.1
1.1
—
—
—
0
0
29
245
1.19
0.35
1.4
1.5
29.9
34.6
%
0.32
23
149
34
293
1.16
0.33
1.1
1.1
—
—
—
0
0
6
89
0.67
0.33
1.2
1.2
—
—
—
0
0
36
313
1.15
0.32
1.3
1.4
—
—
—
0
0
73
666
1.10
0.31
1.8
1.7
—
—
—
0
0
15
120
1.25
0.30
3.0
4.9
—
—
—
0
0
7
56
1.25
0.29
1.4
1.2
—
—
—
0
0
11
140
0.78
0.28
1.1
1.1
—
—
—
0
0
61
556
1.10
0.27
1.7
1.6
—
—
—
0
0
45
501
0.90
0.27
1.4
1.4
7.2
24.9
e6/l
1.97
37
381
34
299
1.14
0.27
1.2
1.2
6.4
3.4
u/ml
0.31
12
75
94
1009
0.93
0.27
2.1
1.9
37.0
39.4
u/l
0.51
84
874
105
1121
0.93
0.26
1.5
2.2
10.2
10.1
g/l
0.07
82
912
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
24
278
0.86
0.26
1.2
1.4
—
—
—
0
0
11
87
1.27
0.24
1.2
1.9
1303.8
924.6
e6/l
—
6
53
9
77
1.17
0.24
1.3
1.2
—
—
—
0
0
21
180
1.17
0.23
1.8
2.2
755.9
622.6
ml
1.18
12
114
11
88
1.25
0.22
1.1
1.2
—
—
—
0
0
16
189
0.85
0.22
1.4
1.3
—
—
—
0
0
1968
19824
0.98
0.22
4.1
4.5
19.1
14.7
mm/h
18.82
1763
18006
34
305
1.12
0.21
1.1
1.1
—
—
—
0
0
5
42
1.19
0.21
1.6
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
5
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
0.8
—
0
5
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
6
11
134
0.82
0.20
1.3
1.6
1.0
1.0
g/l
0.00
11
134
43
393
1.10
0.20
1.3
1.5
1.0
0.8
nmol/l
0.85
31
310
0
14
0.00
0.20
0.0
1.1
—
8.3
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
86
912
0.94
0.20
1.4
1.4
245.1
280.4
ug/g
0.79
47
536
256
2640
0.97
0.19
3.1
3.0
89.5
84.6
ng/l
0.44
203
2155
35
318
1.10
0.18
1.3
1.1
57.8
57.7
u/l
0.00
25
217
2405
24153
0.98
0.18
5.6
5.6
2.1
2.1
mu/l
0.25
2144
21686
12
100
1.20
0.18
1.4
1.8
—
—
—
0
0
32
290
1.10
0.18
1.1
1.1
1.8
100.5
iu/ml
—
6
49
46
497
0.92
0.18
1.8
1.8
—
—
—
0
0
10
121
0.83
0.18
1.2
1.9
16.1
16.2
nmol/l
—
10
109
72
763
0.94
0.17
1.4
1.4
—
—
—
0
0
43
399
1.08
0.16
2.3
2.2
37.5
25.3
mg/l
0.55
15
101
60
637
0.94
0.15
1.9
2.0
10.8
12.0
mg/l
0.58
55
586
10
83
1.21
0.15
1.7
1.6
—
—
—
0
0
20
224
0.89
0.15
1.1
1.2
—
75.5
—
0
13
170
1756
0.97
0.15
2.4
2.8
10.4
10.2
g/l
0.21
151
1584
70
664
1.06
0.14
3.1
3.1
8.1
7.7
mmol/l
0.45
70
652
14
160
0.87
0.14
1.3
1.2
0.0
1.3
u/ml
—
5
75
8
96
0.83
0.13
1.3
1.3
—
—
—
0
0
8
96
0.83
0.13
1.3
1.3
—
—
—
0
0
8
97
0.82
0.13
1.3
1.4
—
—
—
0
0
627
6186
1.02
0.13
1.8
1.8
1316.8
1200.4
nmol/l
1.93
462
4486
11
128
0.86
0.13
1.2
1.1
—
—
—
0
0
68
714
0.95
0.13
1.3
1.6
0.3
0.2
g/l
1.93
63
668
19
211
0.90
0.13
1.1
1.2
—
3.2
—
0
14
9
107
0.84
0.13
1.0
1.0
—
—
—
0
0
79
825
0.96
0.12
1.6
2.2
0.0
0.0
g/l
0.00
66
740
185
1802
1.03
0.12
1.7
1.7
—
—
—
0
0
58
551
1.05
0.12
1.4
1.4
—
—
—
0
0
24
261
0.92
0.11
1.1
1.0
—
—
—
0
0
66
631
1.05
0.11
1.3
1.3
—
—
—
0
0
66
631
1.05
0.11
1.3
1.3
—
—
—
0
0
74
711
1.04
0.10
1.7
1.6
20042.5
12419.5
e6/l
0.46
50
510
78
810
0.96
0.10
1.6
2.2
0.0
0.0
g/l
0.00
66
737
19
173
1.10
0.10
1.7
1.4
—
—
—
0
0
45
474
0.95
0.10
1.3
1.3
—
94.0
—
0
10
11
125
0.88
0.10
1.8
1.3
33.2
20.4
umol/l
0.54
11
120
14
125
1.12
0.10
1.0
1.1
1.1
1.1
u/l
—
8
65
18
197
0.91
0.10
1.3
1.7
—
—
—
0
0
2381
23750
1.01
0.09
6.8
6.3
41.6
40.2
mmol/mol
9.68
2146
21415
13
145
0.90
0.09
1.2
1.2
—
—
—
0
0
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
2493
24877
1.01
0.09
5.3
5.1
6.2
6.0
mmol/l
14.63
2189
22071
20
216
0.93
0.08
1.3
1.5
—
—
—
0
0
13
144
0.90
0.08
1.0
1.1
9.3
12.5
iu/ml
—
5
33
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
71
734
0.97
0.08
1.4
1.6
1.3
1.2
g/l
1.47
66
686
30
283
1.06
0.08
2.1
1.7
9.3
1394.3
u/ml
0.76
30
278
6
73
0.82
0.07
5.7
12.4
0.6
0.6
mmol/l
—
6
67
9
84
1.07
0.07
1.1
1.1
—
—
—
0
0
41
427
0.96
0.06
1.2
1.4
—
—
—
0
0
51
528
0.97
0.06
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
142
0.92
0.06
1.0
1.1
—
—
—
0
0
23
244
0.94
0.06
1.4
1.5
—
—
—
0
0
2109
21045
1.01
0.06
4.7
4.6
15.2
15.1
pmol/l
0.85
1893
18749
13
119
1.09
0.06
1.2
1.3
—
—
—
0
0
13
119
1.09
0.06
1.2
1.3
—
—
—
0
0
13
119
1.09
0.06
1.2
1.3
—
—
—
0
0
13
119
1.09
0.06
1.2
1.3
—
—
—
0
0
35
336
1.04
0.05
1.3
1.5
63.1
58.1
%
0.39
23
211
11
100
1.10
0.05
1.8
1.7
494.2
644.0
e6/l
—
5
42
21
222
0.95
0.05
1.3
1.4
—
—
—
0
0
31
297
1.04
0.05
1.2
1.2
2.5
4.2
u/ml
0.78
20
112
23
242
0.95
0.05
1.3
1.3
—
—
—
0
0
54
526
1.03
0.04
3.8
3.7
111.1
41.7
u/ml
0.82
54
519
10
91
1.10
0.04
1.0
1.1
18.2
433.2
ng/l
—
5
24
15
160
0.94
0.04
1.5
1.5
0.2
0.2
nmol/l
—
8
109
35
339
1.03
0.03
1.3
1.4
—
—
—
0
0
131
1326
0.99
0.03
5.5
6.9
24.5
24.6
mmol/l
0.18
120
1226
39
381
1.02
0.02
1.2
1.2
105.1
29.5
u/l
0.43
32
328
165
1640
1.01
0.01
1.1
1.2
109.8
145.8
iu/ml
0.88
81
596
81
803
1.01
0.01
2.5
3.7
25.8
35.7
u/ml
1.19
76
779
11
116
0.95
0.00
1.1
1.2
—
—
—
0
0
14
146
0.96
0.00
1.2
1.2
—
—
—
0
0
16
166
0.96
0.00
1.3
1.4
—
—
—
0
0
258
2587
1.00
0.00
2.0
2.3
32.7
37.0
u/l
1.20
214
2177
14
135
1.04
0.00
1.4
1.5
—
—
—
0
0
14
135
1.04
0.00
1.4
1.5
—
—
—
0
0
15
151
0.99
0.00
1.3
1.4
—
—
—
0
0
55
549
1.00
0.00
2.6
2.6
1.7
1.6
mg/l
0.15
47
494
12
124
0.97
0.00
1.8
1.6
—
—
—
0
0
1243
12432
1.00
0.00
2.1
2.1
94.8
98.0
pmol/l
1.35
608
5631
5
54
0.93
0.00
1.8
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
7
79
0.89
0.00
1.3
1.2
—
—
—
0
0
5
57
0.88
0.00
3.2
1.9
3.5
2.2
mmol/l
—
5
50
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
6
61
0.98
0.00
1.3
1.3
—
—
—
0
0
15
150
1.00
0.00
1.3
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
9
93
0.97
0.00
1.1
1.9
15.8
389.5
ug/l
—
9
86
0
9
0.00
0.00
0.0
1.0
—
2.3
—
0
9
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.0
—
3.4
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CORPUS_UTERI – Malignant neoplasm of corpus uteri
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).